- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02775760
The Entorhinal Cortex and Aerobic Exercise in Aging (ECE)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02118
- Boston University School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age between 60-80 years
- Physical inactivity/sedentary status (The American College of Sports Medicine defines a sedentary lifestyle as a lifestyle in which a person is not participating in at least 30 minutes of moderate intensity physical activity on at least three days per week for at least three months.)
- Generally healthy
- Living in the greater Boston area
- Fluent in English (must have attended elementary school and higher in English)
- Non-smoking
Exclusion Criteria:
- Poor vision that cannot be corrected with glasses or contact lenses
- Presence of an acute infection
- Diagnosis of kidney failure
- Diagnosis of liver disease
- Diagnosis of thyrotoxicosis/hyperthyroidism
- Diagnosis of cancer
- Diagnosis of severe anemia
Past or present conditions that affect cognitive functioning:
- learning disability
- neurological disorders or conditions (movement disorder, history of head trauma or stroke, epilepsy, etc.)
- psychiatric disorders or conditions within last 5 years (depression, anxiety disorder, etc.)
- Severe stress
- Evidence of cognitive impairment (e.g. dementia)
- Claustrophobia (fear of small, enclosed spaces)
- Obesity
Past or present conditions that are counter indicators for participation in cardio-respiratory fitness assessment and physical exercise:
- heart conditions (e.g. heart attack, arrhythmias, etc.)
- circulatory conditions (e.g. uncontrolled hypertension, leg claudication, high cholesterol, etc.)
- respiratory conditions (e.g., asthma or lung conditions, such as chronic obstructive pulmonary disease, acute bronchitis, acute common cold, lung cancer, pneumonia, etc.)
- current musculoskeletal impairments (e.g. fractures, hemiplegia, chronic joint pain, arthritis, osteoporosis, not able to walk comfortably without assistance, etc.)
- diagnosis of electrolyte disorder or abnormality
- presence of diabetes mellitus
- Prescription medication or other drugs that treat heart, lung, or circulatory conditions (e.g. beta blockers, bronchodilators, etc.)
- Prescription medication or other drugs that affect chemicals in the brain (e.g. antidepressants, anxiolytics, etc.)
- Drug abuse or alcohol misuse
- Metal in or on the body that cannot be removed (e.g. pacemaker, defibrillator, metal implant that is ferrous)
- Some known abnormal MRI findings (case by case basis)
- Regularly exercising
- Unavailable for the approx. 4-month duration of the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Cardiovascular endurance
Participants will undergo cardiovascular endurance training.
The trainer-supervised endurance training will involve walking on a treadmill at moderate intensity
|
Physical exercise at the Boston University Fitness and Recreation Center
|
Active Comparator: Strength, balance, and flexibility
Participants will undergo Strength, balance, and flexibility training.
|
Physical exercise at the Boston University Fitness and Recreation Center
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Functional MRI - Right Subiculum
Time Frame: 0 months-baseline (pre-intervention)
|
The fMRI is measuring blood oxygenation levels and blood flow in different regions of the brain and using that to determine activity changes in the brain. This measurement was obtained while participants were performing a virtual navigation task in the MRI scanner. Data reported for fMRI is in beta-weight for navigation greater control contrast of BOLD images. The beta-weight is a standardized regression coefficient. Higher beta-weights mean greater activation and lower beta-weights mean less activation in specific brain regions being monitored. Negative beta-weights mean lower activation for the navigation condition than for the control condition, positive beta-weights mean greater activation for the navigation condition than for the control condition. |
0 months-baseline (pre-intervention)
|
Structural MRI - Right Dentate Gyrus Head
Time Frame: 0 months-baseline (pre-intervention)
|
Measurement of regional brain volumes in the medial temporal lobes to assess change in regional brain volumes.
Reported outcome measure is volume of the right anterior (i.e., head) dentate gyrus, a hippocampal subfield known to show plasticity in response to exercise in animal models.
The hippocampus is part of the medial temporal lobes.
|
0 months-baseline (pre-intervention)
|
Cognitive Test Performance: Spatial Memory
Time Frame: 4 months
|
Participants will perform a spatial memory test during functional MRI.
Measurements include baseline-to-follow-up change test performance.
|
4 months
|
Cognitive Test Performance: Virtual Navigation
Time Frame: 4 months
|
Participants will perform a virtual navigation test during functional MRI.
Measurements include baseline-to-follow-up change in test performance.
|
4 months
|
Functional MRI - Post-intervention Right Subiculum
Time Frame: 4 months
|
The fMRI is measuring blood oxygenation levels and blood flow in different regions of the brain and using that to determine activity changes in the brain. This measurement was obtained while participants were performing a virtual navigation task in the MRI scanner. Data reported for fMRI is in beta-weight for navigation greater control contrast of BOLD images. The beta-weight is a standardized regression coefficient. Higher beta-weights mean greater activation and lower beta-weights mean less activation in specific brain regions being monitored. Negative beta-weights mean lower activation for the navigation condition than for the control condition, positive beta-weights mean greater activation for the navigation condition than for the control condition. |
4 months
|
Structural MRI - Post-intervention Right Dentate Gyrus Head
Time Frame: 4 months
|
Measurement of regional brain volumes in the medial temporal lobes to assess change in regional brain volumes.
Reported outcome measure is volume of the right anterior (i.e., head) dentate gyrus, a hippocampal subfield known to show plasticity in response to exercise in animal models.
The hippocampus is part of the medial temporal lobes.
|
4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Aerobic Capacity
Time Frame: 4 months
|
Participants will perform a treadmill test to estimate baseline-to-follow-up change in aerobic capacity.
Aerobic capacity is the maximum amount of oxygen (O2;(expressed in volume: VO2) a person can utilize during strenuous exercise.
This maximum volume of oxygen is known as VO2max or aerobic capacity.
For this study, we measured heart rate during the treadmill test and estimated VO2max from heart rate, thus we estimated VO2max rather than measured oxygen and carbondioxyde in the breath while exercising.
VO2max is expressed in milliliters per kilogram of body weight per minute (ml/kg/min).
We calculated percentage change from baseline to post-intervention.
|
4 months
|
Muscle Strength
Time Frame: 4 months
|
Participants will perform several muscle strength tests to estimate baseline-to-follow-up change in muscle strength.
Percentage change in chess press weight lifted is reported in results.
|
4 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body composition measurement
Time Frame: 12 weeks
|
Measurement of lean body mass with bio-electrical impedance analysis (BIA) to estimate baseline-to-follow-up change in lean body mass.
|
12 weeks
|
Neuropsychological test score: spatial reasoning
Time Frame: 12 weeks
|
Participants will perform several neuropsychological tests of spatial reasoning to measure baseline-to-follow-up change in spatial reasoning ability.
A composite score will be calculated.
|
12 weeks
|
Neuropsychological test score: spatial cognition
Time Frame: 12 weeks
|
Participants will perform several neuropsychological tests of spatial cognition to measure baseline-to-follow-up change in spatial cognition.
A composite score will be calculated.
|
12 weeks
|
Neuropsychological test score: verbal memory
Time Frame: 12 weeks
|
Participants will perform a neuropsychological test of verbal memory to measure baseline-to-follow-up change in verbal memory.
|
12 weeks
|
Neuropsychological test score: visuospatial memory
Time Frame: 12 weeks
|
Participants will perform a neuropsychological test of visuospatial memory to measure baseline-to-follow-up change in memory.
|
12 weeks
|
Neuropsychological test score: executive function
Time Frame: 12 weeks
|
Participants will perform a neuropsychological test of executive function to measure baseline-to-follow-up change in executive function.
|
12 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Karin Schon, PhD, Boston University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
- memory
- physical activity
- magnetic resonance imaging
- exercise
- cognition
- functional neuroimaging
- exercise test
- learning
- body composition
- walking
- brain
- executive function
- resistance training
- attention
- physical fitness
- neuropsychological tests
- hippocampus
- muscle stretching exercises
- physical endurance
- spatial navigation
- brain mapping
- entorhinal cortex
Other Study ID Numbers
- H-34579
- R21AG049968 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aging
-
Tuba MadenCompletedAging | Aging Problems | Aging Disorder
-
Radboud University Medical CenterNot yet recruitingAging | Aging Well | Immuno Aging
-
University of Santiago de CompostelaEuropean Regional Development Fund; Center for Industrial Technological Development...Completed
-
TruDiagnosticBlushield USANot yet recruitingAging | Aging Well
-
San Diego State UniversityCompleted
-
Lithuanian Sports UniversityCompletedAging | Healthy AgingLithuania
-
Amazentis SAproDERM GmbHCompleted
-
Northumbria UniversityUniversity of East AngliaSuspendedSleep | Aging | Healthy AgingUnited Kingdom
-
University of West AtticaNot yet recruiting
-
University of Santiago de CompostelaAgencia Estatal de Investigación, SpainRecruiting
Clinical Trials on Cardiovascular endurance
-
Universitair Ziekenhuis BrusselNot yet recruiting
-
University of GiessenHannover Medical SchoolUnknownType 2 DiabetesGermany
-
Schön Klinik Berchtesgadener LandCompletedChronic Obstructive Pulmonary DiseaseGermany
-
General Committee of Teaching Hospitals and Institutes...Cairo University; Taibah UniversityCompleted
-
University of CincinnatiCompletedStroke, Ischemic | Dysphagia, Oral PhaseUnited States
-
Riphah International UniversityCompleted
-
Norwegian University of Science and TechnologyLHL-Klinikkene, Røros; LHL-Klinikkene, FeiringWithdrawnVentricular Dysfunction, Left | Heart Failure, DiastolicNorway
-
Molde University CollegeCompleted
-
University of VigoCompletedQuality of Life | Physical Activity | Parkinson Disease | ExerciseSpain
-
Goethe UniversityCompleted